Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,933 | 114,185 | 1,654 | 0 | N/A |
| Marketable Securities | 131,149 | N/A | N/A | 0 | N/A |
| TOTAL | $207,610 | $114,243 | $1,705 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 7,751 | 1,264 | 352 | 0 | N/A |
| Other Non-Current Assets | 1,539 | 1,838 | 68 | 0 | 0 |
| TOTAL | $9,290 | $3,102 | $420 | $N/A | $N/A |
| Total Assets | $216,900 | $117,345 | $2,125 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,397 | 2,166 | 393 | 0 | 0 |
| Accrued Expenses | 5,523 | 1,737 | 263 | 0 | N/A |
| TOTAL | $10,920 | $5,103 | $1,056 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 586 | 1,304 | 438 | 0 | N/A |
| Other Non-Current Liabilities | 0 | 137,659 | 11,747 | 0 | 0 |
| TOTAL | $586 | $138,963 | $12,185 | $N/A | $N/A |
| Total Liabilities | $11,506 | $144,066 | $13,241 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,959 | N/A | N/A | N/A | N/A |
| Common Shares | 39 | 7 | 7 | 0 | N/A |
| Retained earnings | -82,612 | -27,832 | -11,123 | 0 | N/A |
| Other shareholders' equity | 30 | 0 | 0 | 0 | 0 |
| TOTAL | $205,394 | $-26,721 | $-11,116 | $0 | $N/A |
| Total Liabilities And Equity | $216,900 | $117,345 | $2,125 | $0 | $0 |